These idiopathic cases had mild elevations of PRL and, importantly, all of them had a marked response (i.e., > 300% from baseline PRL) to the metoclopramide test, thus not in favor of picoprolactinomas (i.e., maximal size of adenoma < 3 mm, usually not visualized on pituitary MRI). This evidence concerns the gene PRL and adenoma.